CIK 0001832038 · <br>Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851403134
- Phone
- (781) 819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,089
- in 5 filings, $177K under 10b5-1 plans
Net −$177,089. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Andersen Jill −$53K Chief Legal Officer, Secretary sold 19% of stake
- Duke William E. −$32K Chief Financial Officer sold 19% of stake
- Green Julie −$32K Chief Human Resources Officer sold 19% of stake
- Lee Timothy Edward −$32K Chief Commercial Officer sold 19% of stake
- Allen Robert D. III −$29K Chief Scientific Officer sold 17% of stake
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-18 | Hering David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2023-12-18 | Schmidt Peter Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2023-12-18 | Price Stacy Chief Tech. and Manuf. Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2023-12-18 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2023-12-18 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-12-18 | Allen Robert D. III Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2023-11-17 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2023-09-01 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2023-07-25 | Cotter Sara Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-05-23 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Heyman Tomas J. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | WYZGA MICHAEL S Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Lindenboom Christine Director | Grant or award · Stock Option (Right to Buy) | +29,589 | 29,589 | ||
| 2023-05-23 | MEANWELL CLIVE Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Berry Tamsin Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-04-11 | Allen Robert D. III Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2023-03-27 | Price Stacy Chief Tech. and Manuf. Officer | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 | ||
| 2022-12-16 | Gowler Jeremy COO & CCO | Grant or award · Stock Option (Right to Buy) | +625,000 | 625,000 | ||
| 2022-12-14 | Dabora Rebecca Chief Tech and Manuf Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 7 of 9 · 161 trades